Simcere Pharmaceutical Group Limited (HKG:2096)
Hong Kong
· Delayed Price · Currency is HKD 11.92
-0.18 (-1.49%)
Apr 29, 2026, 4:08 PM HKT
HKG:2096 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 30,788 | 31,071 | 17,653 | 17,611 | 30,914 | 23,628 | Upgrade
|
| Market Cap Growth | 43.47% | 76.01% | 0.24% | -43.03% | 30.83% | 1.20% | Upgrade
|
| Enterprise Value | 28,135 | 29,485 | 15,639 | 16,205 | 29,371 | 23,209 | Upgrade
|
| Last Close Price | 11.92 | 11.97 | 6.98 | 6.42 | 10.84 | 8.23 | Upgrade
|
| PE Ratio | 19.84 | 20.77 | 22.63 | 22.37 | 29.38 | 12.77 | Upgrade
|
| Forward PE | 13.35 | 16.58 | 14.35 | 12.11 | 29.04 | 26.63 | Upgrade
|
| PS Ratio | 3.58 | 3.61 | 2.50 | 2.42 | 4.32 | 3.85 | Upgrade
|
| PB Ratio | 2.94 | 2.97 | 2.35 | 2.21 | 3.83 | 2.98 | Upgrade
|
| P/TBV Ratio | 3.54 | 3.57 | 2.81 | 2.51 | 4.16 | 3.10 | Upgrade
|
| P/FCF Ratio | - | - | 16.04 | - | 27.04 | - | Upgrade
|
| P/OCF Ratio | - | - | 11.93 | 105.83 | 20.19 | - | Upgrade
|
| PEG Ratio | - | 1.12 | 1.12 | 1.12 | 1.12 | 1.12 | Upgrade
|
| EV/Sales Ratio | 3.27 | 3.43 | 2.22 | 2.23 | 4.11 | 3.78 | Upgrade
|
| EV/EBITDA Ratio | 15.42 | 16.15 | 10.83 | 15.90 | 31.86 | 44.76 | Upgrade
|
| EV/EBIT Ratio | 17.86 | 18.70 | 12.97 | 20.69 | 42.85 | 81.03 | Upgrade
|
| EV/FCF Ratio | - | - | 14.21 | - | 25.69 | - | Upgrade
|
| Debt / Equity Ratio | 0.13 | 0.13 | 0.17 | 0.20 | 0.21 | 0.25 | Upgrade
|
| Debt / EBITDA Ratio | 0.72 | 0.72 | 0.84 | 1.43 | 1.72 | 3.50 | Upgrade
|
| Debt / FCF Ratio | - | - | 1.17 | - | 1.49 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.25 | -0.25 | -0.10 | -0.08 | -0.16 | -0.08 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.46 | -1.46 | -0.54 | -0.64 | -1.37 | -1.30 | Upgrade
|
| Net Debt / FCF Ratio | - | - | -0.71 | 1.77 | -1.10 | 1.33 | Upgrade
|
| Asset Turnover | 0.59 | 0.59 | 0.59 | 0.61 | 0.60 | 0.47 | Upgrade
|
| Inventory Turnover | 2.23 | 2.23 | 1.80 | 2.84 | 4.01 | 3.59 | Upgrade
|
| Quick Ratio | 1.93 | 1.93 | 1.73 | 1.76 | 1.69 | 1.51 | Upgrade
|
| Current Ratio | 2.21 | 2.21 | 2.00 | 2.10 | 1.84 | 1.63 | Upgrade
|
| Return on Equity (ROE) | 16.31% | 16.31% | 10.26% | 9.94% | 13.62% | 25.41% | Upgrade
|
| Return on Assets (ROA) | 6.75% | 6.75% | 6.33% | 4.11% | 3.62% | 1.38% | Upgrade
|
| Return on Invested Capital (ROIC) | 17.91% | 18.83% | 15.63% | 10.83% | 10.15% | 4.14% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.50% | 12.50% | 12.90% | 8.70% | 7.80% | 3.30% | Upgrade
|
| Earnings Yield | 4.86% | 4.81% | 4.42% | 4.47% | 3.40% | 7.83% | Upgrade
|
| FCF Yield | - | - | 6.23% | -2.08% | 3.70% | -2.14% | Upgrade
|
| Dividend Yield | 1.70% | 1.67% | 2.44% | 2.74% | 1.67% | 2.24% | Upgrade
|
| Payout Ratio | - | - | 54.76% | 58.65% | 42.04% | 25.96% | Upgrade
|
| Buyback Yield / Dilution | 1.25% | 1.25% | 3.40% | 0.45% | -0.34% | -9.14% | Upgrade
|
| Total Shareholder Return | 2.93% | 2.92% | 5.83% | 3.19% | 1.32% | -6.91% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.